AMY STEWARD: Open Payments
NPI 1134372907 · ALLEGAN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,579 in 132 payments from 25 companies in 2025. Trend: 2023 $1,924 · 2024 $1,831 · 2025 $2,579
Food & beverage: $2,480Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $288 |
| Novo Nordisk Inc | 14 | $242 |
| AstraZeneca Pharmaceuticals LP | 10 | $241 |
| GlaxoSmithKline, LLC. | 15 | $209 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $202 |
| Amgen Inc. | 12 | $201 |
| PFIZER INC. | 16 | $184 |
| ABBVIE INC. | 9 | $145 |
| Lundbeck LLC | 5 | $141 |
| Axsome Therapeutics, Inc. | 6 | $136 |
Products named: TRELEGY ELLIPTA, Kerendia, Veozah, REXULTI, FARXIGA, VRAYLAR, Auvelity, EVENITY.
Industry payments across MI — which companies pay providers there.
